Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2019

May 15, 2019

SELL
$62.53 - $70.05 $4.88 Million - $5.46 Million
-78,000 Closed
0 $0
Q4 2018

Feb 14, 2019

SELL
$60.54 - $79.0 $2,118 - $2,765
-35 Reduced 0.04%
78,000 $4.88 Million
Q3 2018

Nov 14, 2018

BUY
$71.28 - $78.92 $572,734 - $634,122
8,035 Added 11.48%
78,035 $6.03 Million
Q1 2018

May 11, 2018

BUY
$72.84 - $88.8 $5.1 Million - $6.22 Million
70,000 New
70,000 $5.28 Million

Others Institutions Holding GILD

About GILEAD SCIENCES, INC.


  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $116B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Advent Capital Management Portfolio

Follow Advent Capital Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Advent Capital Management , based on Form 13F filings with the SEC.

News

Stay updated on Advent Capital Management with notifications on news.